Biotron Limited Total Revenue

The latest total revenue for BITRF is $2.3M as of June 2026. That compares with $3.1M in the prior-year period — down 24.0% year over year. That is below the Healthcare sector average of $540B. Investors often review this figure alongside Biotron Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BITRF's total revenue moved from $3.1M to $2.3M — a 24.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biotron Limited's operating scale or balance-sheet position.

Against Healthcare companies, BITRF currently prints $2.3M for total revenue, while the sector average sits near $540B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Biotron Limited's growth, margins, and balance sheet.

A total revenue figure of $2.3M for BITRF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $540B. Explore the charts below for those layers of context.

After noting BITRF's total revenue ($2.3M), review year-over-year change from $3.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.